Start Submission

Reading: Treatment outcome for NRTI-sparing regimen consisting of dolutegravir and rilpivirine in HIV...

Download

A- A+
Alt. Display

Conference/Meeting Abstract Proceedings

Treatment outcome for NRTI-sparing regimen consisting of dolutegravir and rilpivirine in HIV-1 infected patients

Authors:

Mari Kato ,

National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan, JP
X close

Hiroaki Togami,

National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan, JP
X close

Atsushi Hirano,

National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan, JP
X close

Naoko Fukushima,

National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan, JP
X close

Shuuichi Matsumoto,

National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan, JP
X close

Yoshiyuki Yokomaku,

National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan, JP
X close

Masaaki Takahashi

National Hospital Organization Suzuka National Hospital, Suzuka, Mie, Japan, JP
X close

Abstract

How to Cite: Kato, M., Togami, H., Hirano, A., Fukushima, N., Matsumoto, S., Yokomaku, Y. and Takahashi, M., 2017. Treatment outcome for NRTI-sparing regimen consisting of dolutegravir and rilpivirine in HIV-1 infected patients. European Journal of Molecular & Clinical Medicine, 1, p.18. DOI: http://doi.org/10.1016/j.nhccr.2017.06.175
34
Views
38
Downloads
Published on 07 Sep 2017.
Peer Reviewed

Downloads

  • PDF (EN)